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Abstract
Background: Detecting serum antibody against inhaled antigens is an important diagnostic adjunct
for hypersensitivity pneumonitis (HP). We sought to validate a quantitative fluorimetric assay
testing serum from bird fanciers.
Methods: Antibody activity was assessed in bird fanciers and control subjects using various avian
antigens and serological methods, and the titer was compared with symptoms of HP.
Results: IgG antibody against pigeon serum antigens, quantified by fluorimetry, provided a good
discriminator of disease. Levels below 10 mg/L were insignificant, and increasing titers were
associated with disease. The assay was unaffected by total IgG, autoantibodies and antibody to
dietary hen's egg antigens. Antigens from pigeon serum seem sufficient to recognize immune
sensitivity to most common pet avian species. Decreasing antibody titers confirmed antigen
avoidance.
Conclusion:  Increasing antibody titer reflected the likelihood of HP, and decreasing titers
confirmed antigen avoidance. Quantifying antibody was rapid and the increased sensitivity will
improve the rate of false-negative reporting and obviate the need for invasive diagnostic
procedures. Automated fluorimetry provides a method for the international standardization of HP
serology thereby improving quality control and improving its suitability as a diagnostic adjunct.
Background
Hypersensitivity pneumonitis (HP) is an immune-medi-
ated pulmonary disease caused by repeated inhalation of
mainly microbial and animal (glyco-) protein dusts. The
most common syndromes are bird fanciers' lung and
farmers' lung. HP forms a substantial and important sub-
group of interstitial lung diseases [1], which are disorders
that primarily affect the lung parenchyma in a diffuse
manner [2]. The symptoms include shortness of breath
without wheeze, general malaise and aching discomfort in
the joints and muscles. There is associated pyrexia with
rigors and sweating, and an unproductive cough, which
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occur generally several hours after exposure to the anti-
genic dust. Recently it was recommended that the assess-
ment of interstitial lung disease should include testing for
antibody against antigens associated with HP [2], how-
ever, the diagnosis of HP itself is difficult [3-6]. In a recent
review of the diagnostic criteria it was concluded that the
presence of serum precipitating antibody was a major
diagnostic index [5,6]. Precipitins are a qualitative test
and cases of undiagnosed HP have been attributed to
improper quality control [3]. In this regard there have
been recent recommendations from an HP workshop that
diagnostic tests are evaluated [7], and from a national
quality assurance scheme that antibody tests be developed
that are amenable to standardization [8] and that are
quantitative [9]. The aim of this study was to assess vari-
ous antigens and procedures for quantifying serum anti-
body in bird fanciers' hypersensitivity pneumonitis.
Methods
Study groups: bird fanciers
50 volunteer pigeon fanciers attending a convention were
selected for doctor administered structured questionnaire
regarding the nature and frequency of symptoms relating
to avian exposure. The questionnaire has been validated
[10], and subjects were categorized into three groups
depending on the likelihood of having HP. Those describ-
ing at least 3 respiratory and 3 systemic symptoms occur-
ring together 4–8 hours after pigeon exposure on at least
3 occasions in the last 3 months were categorized as 'Prob-
able' HP [n = 22]. Those with indeterminate symptoms
but which did not fulfill the criteria of above were classi-
fied as 'Possible' [n = 10], and those with no symptoms
associated with pigeon exposure were classified as
'Unlikely' [n = 18] to have HP [10,11]. All were non-
smokers.
Subjects signed an informed consent proforma and
donated a blood sample. The Medical Ethics Committee
of Stobhill Hospital approved the study (ref. 00/44).
Archive sera were available from other bird fanciers who
kept the following species: parakeet (budgerigar in UK) (n
= 46), cockatiel (n = 13), parrot (n = 11), finch (n = 4),
and canary (n = 4).
Study groups: control subjects
Serum samples were obtained from subjects with no sig-
nificant contact with pigeons. This included 54 normal
healthy adults, and pathological control samples that
were selected from archive SLE sera with high levels of
auto-antibodies (n = 7), myeloma sera with high levels of
total IgG (n = 10), and celiac disease sera with high levels
of IgG antibody to hen's egg antigens (n = 32).
Antigens
Serum from the following avian species; pigeon (Columbia
livia), finch (Carduelis sp.), canary (Serinus sp.), cockatiel
(Nymphicus sp.), parakeet/budgerigar (Melopsittacus undu-
latus), and parrot (Psittacidae) was a kind gift of Tom Pen-
nicote, Agricultural Research Station, Auchincruive,
Scotland.
Detection of serum antibody activity against avian 
antigens
Automated fluorimetry
A solid-phase indirect enzyme immuno-assay automated
system was used according to the manufacturer's instruc-
tions (UniCAP 100, Sweden Diagnostics (UK) Ltd, Milton
Keynes, UK). The antigens (code reference) were pigeon
serum (Ge93), droppings (e7), and feathers (Re215), and
budgerigar serum (e79), feathers (e78), and droppings
(e77). When all reagents were in excess, the fluorescence
was proportional to the concentration of serum IgG anti-
body, and the titer was calculated by interpolation onto a
6-point standard curve generated by the fluorescence from
standard samples of known IgG titer (traceable to WHO
International Reference 67/86).
Enzyme immunoassay (EIA)
Serum IgG antibody activity against avian serum antigens
was measured by indirect EIA [9]. Optimal conditions
established by checkerboard analysis were serum antigen
at 5 ug/ml (approximately 1:1000 dilution), and test
serum samples diluted at 1:200. The IgG antibody activity
was quantified by interpolation, using an optical density
standard curve from serial dilutions of a standard serum
that had been titrated by quantitative precipitation using
pigeon serum gamma globulin antigen [12]. Optical den-
sity units were used as a relative measure of the IgG anti-
body activity against other avian antigens. The specificity
of the assay was established by inhibiting the antibody
activity in serum with excess free antigen before assay.
Precipitin tests for antibody
Serum precipitating antibody against pigeon serum (both
Neat and N/10 dilution) was demonstrated by Ouchterl-
ony double diffusion in agar, and the number of precipi-
tin bands that were visible using a microscope eyepiece
and indirect lighting was counted.
Statistical analysis
Results are expressed as median and inter-quartile range
unless otherwise specified. Differences between the
groups were analyzed using the Mann-Whitney U-test and
analysis of variance. The IgG antibody titers measured by
fluorimetry and by EIA, against pigeon and budgie anti-
gens generated skewed data therefore the correlation coef-
ficient between them was calculated after square rootBMC Pulmonary Medicine 2006, 6:16 http://www.biomedcentral.com/1471-2466/6/16
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transformation. Statistical significance was accepted at the
95% level.
Results
Serum IgG antibody activity against pigeon antigens 
among pigeon fanciers and control subjects measured by 
fluorimetry
The titer of serum IgG antibody against antigens derived
from pigeon serum, feathers and droppings were signifi-
cantly higher among 50 pigeon fanciers than 38 control
subjects (Table 1, p < 0.001 for all).
The control subjects consisted of 21 healthy subjects and
17 pathological control subjects with either IgG myeloma
[n = 10]; to test for the effects of high titers of total IgG on
the assay, or SLE [n = 7]; to test for the effects of high titers
of polyclonal multi-organ specific auto-antibodies on the
assay. The antibody activity in these pathological sera was
marginally higher than in the healthy sera for serum and
feather antigens (p < 0.01).
The effect of antibody sensitization to dietary avian 
antigens on the detection of antibody to inhaled avian 
antigens
Serum from patients with celiac disease [n = 32] had high
titers of IgG to food antigens, including wheat, milk and
hen's egg antigens. The serum IgG antibody titer against
pigeon serum in these patients was not different from 32
normal healthy serum [mean (SD) ug/ml, 0.24 (0.08),
and 0.23 (0.07), respectively, p = 0.88].
Serum IgG antibody activity against various avian antigens 
in pigeon fanciers according to symptom category
Among the 50 pigeon fanciers there were 22 with a typical
symptom profile of HP [categorized as 'Probable' HP], 10
with indeterminate symptoms ['Possible' HP], and 18
with no significant symptoms caused by avian exposure
[categorized as 'Unlikely' to have HP]. The age and gender,
and the various avian exposures indices of years keeping
pigeons, numbers of pigeons kept and daily hours spent
in contact with pigeons were no different between the
groups. The serum IgG antibody activity against pigeon
serum, droppings and feathers antigens, according to
symptom category is listed on Table 2. Those with either
'Probable' or 'Possible' HP could be discriminated from
those in the 'Unlikely' category by having significantly
higher serum IgG antibody titers against all antigens (p <
0.001 for each). Those with 'Probable' HP could be dis-
criminated from those with 'Possible' HP by having signif-
icantly higher antibody titer to antigens from pigeon
serum (p = 0.04).
Table 1: Serum IgG antibody (median and i-q range, µg/ml) against pigeon antigens quantified by fluorimetry in pigeon fanciers, and in 
healthy and pathological control subjects with no significant avian exposure.
Pigeon fanciers Control subjects
Healthy Pathologic
Number 50 21 17
Pigeon serum 37.7 0.01 2.5
(4.9–133.0) (0.01-0.01) (0.01–8.9)
Pigeon feathers 128.0 0.01 3.8
(33.2–250.0) (0.01–2.5) (1.00–4.7)
Pigeon droppings 202.5 21.9 28.2
(59.8–250.0) (14.1–26.2) (19.1–42.8)
Table 2: Serum IgG antibody (median and i-q range, µg/ml) against pigeon antigens quantified by fluorimetry in pigeon fanciers 
according to category of likelihood of Hypersensitivity Pneumonitis, based on symptoms.
Category of likelihood of HP
Probable Possible Unlikely
Number 22 10 18
Pigeon serum 135.0 70.3 3.4
(49.6–161.0) (23.0–94.9) (0.01–11.1)
Pigeon feathers 250.0 174.0 12.4
(142.5–250.0) (80.0–250.0) (2.3–86.4)
Pigeon droppings 250.0 250.0 43.2
(250.0-250.0) (121.5–250.0) (26.2–101.8)BMC Pulmonary Medicine 2006, 6:16 http://www.biomedcentral.com/1471-2466/6/16
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Antibody activity against different avian species antigens
HP can occur with exposure to many species of pet birds
therefore we explored the necessity for using a range of
avian species antigens to test for specific immune sensiti-
zation. In the first experiment, we compared the antibody
activity in 50 pigeon fanciers against either pigeon serum
antigens or budgerigar serum antigens (Figure 1). This
showed that there was almost equivalent antibody activity
detected using either antigen. We then tested the sera of 6
batches of different bird fanciers against serum antigens
from each of these different bird species; pigeon, budgeri-
gar, finch, cockatiel, parrot and canary. There was a signif-
icant correlation between the antibody activity against
each antigen and any of the other antigens (p < 0.001 for
all) irrespective of the test antigen or the bird specie to
which the subject was exposed. This demonstration of
extensive antigenic identity between the avian sera was
further confirmed by the demonstration that adding 5 ul
of pigeon serum to any subject's serum resulted in >90%
inhibition of subsequent detection of antibody activity.
Antibody activity measured by automated fluorimetry and 
by EIA
The IgG antibody against pigeon serum antigens meas-
ured by automated fluorimetry and by EIA was compared
(Figure 2). Analysis of variance showed that there was no
evidence of curvature or a non-zero intercept. Regression
analysis demonstrated a correlation coefficient r = 0.923
(p < 0.0001), and the regression equation was: [IgG anti-
body] Fluorimeter = a [IgG antibody] EIA, where the con-
stant of proportionality a has a value of 0.42 (95% C.I. =
0.31 – 0.54). This suggested that the antibody concentra-
tion measured by either technique correlated, but that the
antibody concentration measured by EIA was consistently
lower than the antibody concentration measured by fluor-
imetry. The reason for that is because the EIA standard
sera were quantified against the gamma-globulin fraction
Comparison of the concentrations of serum IgG antibody [ug/ml] against pigeon serum antigens and budgerigar serum quanti- fied by automated fluorimetry in 50 pigeon fanciers Figure 1
Comparison of the concentrations of serum IgG antibody [ug/ml] against pigeon serum antigens and budgerigar serum quanti-
fied by automated fluorimetry in 50 pigeon fanciers. A transformed (square root) scale has been used on both axes.
IgG antibody [pigeon]
I
g
G
 
a
n
t
i
b
o
d
y
 
[
b
u
d
g
i
e
]
16 14 12 10 8 6 4 2 0
12
10
8
6
4
2
0
r = 0.96, p < 0.001BMC Pulmonary Medicine 2006, 6:16 http://www.biomedcentral.com/1471-2466/6/16
Page 5 of 8
(page number not for citation purposes)
of pigeon serum and would therefore underestimate the
antibody activity against whole serum, which will include
other major antigens such as albumin.
Comparison of antibody activity using EIA and precipitin 
techniques
Precipitin in gel techniques are commonly used to iden-
tify antibody as a diagnostic adjunct in HP. In order to
identify the detection limit of precipitins we quantified
the serum antibody activity against pigeon serum in
archived serum from 50 pigeon fanciers by EIA, and com-
pared this with precipitin formation. The antibody titer
(mean [SD] ug/ml) of the 31 precipitin-positive subjects
was 63 [21] and of the 19 precipitin-negative subjects was
22 [14], (p < 0.001).
Decrease of the antibody titers after antigen avoidance
The longitudinal serum IgG antibody levels against
pigeon serum antigens was quantified by EIA in 7 pigeon
fanciers who gave up their birds after being diagnosed
with HP. Compared with the titer on the first day after
removal of antigen, the antibody titers decreased over
time is shown on Figure 3. The best estimate of the exper-
imental half-life of this decrease can be calculated from
the composite regression equation: Natural log [IgG anti-
body] = 3.86 - 0.007 days.
This was consistent with an antibody half-life of approxi-
mately 95 days when antigen exposure was discontinued.
Thus monitoring sequential changes of antibody titer at
follow-up clinics was a useful indicator to confirm antigen
avoidance.
Discussion
For the serological investigation of hypersensitivity pneu-
monitis among bird fanciers we describe the application
of an automated standardized fluorometric assay that is
unaffected by antibody to dietary avian antigens, multi-
organ specific autoantibody and hyper-gammaglobuli-
naemia. Two recent reports have emphasized the impor-
Comparison of the concentrations of serum IgG antibody [ug/ml] against pigeon serum antigens quantified by both in-house  enzyme immunoassay [EIA] and by automated fluorimetry in 50 pigeon fanciers Figure 2
Comparison of the concentrations of serum IgG antibody [ug/ml] against pigeon serum antigens quantified by both in-house 
enzyme immunoassay [EIA] and by automated fluorimetry in 50 pigeon fanciers. A transformed (square root) scale has been 
used on both axes.
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tance of testing for antibody against antigens associated
with HP. The Standards of Care Committee of the British
Thoracic Society recommended this in the assessment of
interstitial lung disease [2], and the international Hyper-
sensitivity Pneumonitis Study Group has confirmed this
as an important diagnostic adjunct [6]. We would like to
extend this, and recommend that the method used to
detect this antibody should be quantitative and amenable
to international standardization [8,9].
We suggest that automated fluorimetry provides a suitable
method for quantifying serum antibody using the exam-
ple of bird fanciers' HP. We would recommend an anti-
body level greater than 10 mg/L as confirmation of
significant antigen exposure. This value was based on the
upper quartile levels of 8.9 mg/L from pathological con-
trol samples, and 11.1 mg/L in the pigeon fanciers who
were unlikely to have HP. IgG antibody levels above this
we suggest reflect increasing likelihood of HP, for exam-
ple, pigeon fanciers with symptoms suggesting possible
HP had a median level of 70 mg/L, and those with proba-
ble HP had a median level of 135 mg/L.
The technical aspects of the fluorimetric assay are impor-
tant. It is sensitive; with a resolution of 0.1 mg/L, and is
linear over several orders of magnitude up to 250 mg/L,
which covers the useful dynamic range of antibody titers
for this disease [9]. We suggest that pigeon serum is the
cleanest and most comprehensive avian antigen for test-
ing sensitivity to most common pet bird species [13]. The
assay is robustly standardized against an international IgG
standard. It was more sensitive than the more commonly
used precipitin formation, which is limited to detecting
antibody greater than approximately 40 ug/ml. This
increased sensitivity may identify patients with antibody
below this level [3,9], with subacute disease or with dis-
ease of insidious onset [14], all of which would have been
missed by using precipitin formation. Insidious onset is a
clinically important subset of HP and these subjects may
be represented in our HP 'Unlikely' category because of
the lack of acute symptoms. These subjects also tend to
Longitudinal decreasing serum IgG antibody [ug/ml] quantified by EIA in days since the last avian contact in 7 pigeon fanciers  shown as individual lines Figure 3
Longitudinal decreasing serum IgG antibody [ug/ml] quantified by EIA in days since the last avian contact in 7 pigeon fanciers 
shown as individual lines. A transformed (square root) scale has been used on the x-axis.
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have serum antibody titers difficult to detect by precipitins
[20], and therefore a more sensitive quantitative assay
would be of value for earlier detection to minimize dis-
ease progression. This is very important for patients in
whom invasive diagnostic procedures including biopsy
can be avoided if proper serologic tests are performed
using an accurate and reliable reference assay [3,4].
The value of quantifying serum antibody in HP in relation
to symptoms is still contentious because many asympto-
matic subjects can be sero-positive [15,16]. In cases of
antibody positive subjects without symptoms, we and
others [14] have found raised levels of serum C-reactive
protein, TNF-α and total IgG suggesting active systemic
inflammation, as well as physiological evidence of lung
inflammation, including increased alveolar permeability
[17] and bronchial wall thickness [18]. These observa-
tions suggest that the antibody may reflect sub-clinical
inflammation, and that individuals only become sympto-
matic when this inflammation is advanced. This concept
is important because HP frequently presents as a chronic
disease, and until this hypothesis is resolved it is impor-
tant to monitor longitudinal changes in titer.
More than 25 million people in USA keep budgerigars,
canaries or parrots [19], and budgerigars are the main
source of HP in Britain [20]. There are up to 80,000 regis-
tered pigeon fanciers in Britain, and there are similar pro-
portions in many other countries worldwide [Dr.P.Lynch,
President, British National Flying Club, personal commu-
nication], and up to 16% of these can have symptoms in
keeping with HP [10-12]. It is important therefore to
establish an international epidemiological evidence-base
for research into this important disease. Using the meth-
ods above it may be possible to provide a standardized
approach, and automated fluorimetry will greatly facili-
tate this in diagnostic laboratories.
Conclusion
Hypersensitivity Pneumonitis is an important example of
Interstitial Lung Disease, and is currently being re-assessed
in terms of diagnosis and pathogenesis, for which detect-
ing serum antibody is an important adjunct. There is cur-
rently no standardized method for doing this so we
propose that an automated and verifiable method be
adopted that can be used to compare international studies
on diagnosis and pathogenesis. In this pilot study, we
describe an automated fluorimetric method that provides
for international standardization thereby improving qual-
ity control and improving its suitability as a diagnostic
adjunct. Using this we find that serum from pigeon is a
sufficient antigen to detect antibody in subjects who are
exposed to most common pet bird species. We find
increasing antibody titer reflected the likelihood of HP,
and decreasing titers in longitudinal studies confirmed
antigen avoidance. A much larger study will be required to
establish the true sensitivity and specificity of quantifying
antibody in the diagnosis of HP and we recommend that
the first step to achieve this would be to use a standardized
method such as automated fluorimetry which could be a
reference for all workers in this field. Quantifying anti-
body was rapid and the increased sensitivity will improve
the rate of false-negative reporting and obviate the need
for invasive diagnostic procedures.
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